Emcure Pharmaceuticals Ltd (EMCURE) — Cash Flow Reinvestment Rate
Emcure Pharmaceuticals Ltd (EMCURE) has a Cash Flow Reinvestment Rate of 0.50x as of September 2025, reinvesting Rs1.29 Billion (capex Rs1.29 Billion ) from operating cash flow of Rs2.56 Billion. See Emcure Pharmaceuticals Ltd (EMCURE) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Emcure Pharmaceuticals Ltd Cash Flow Reinvestment Rate (2022–2026)
Historical reinvestment intensity for Emcure Pharmaceuticals Ltd across 5 annual periods. For the full cash flow conversion analysis, see Emcure Pharmaceuticals Ltd cash flow conversion.
Annual Cash Flow Reinvestment Rate for Emcure Pharmaceuticals Ltd (2022–2026)
Year-by-year capital reinvestment analysis for Emcure Pharmaceuticals Ltd. See EMCURE financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.42x | Rs3.61 Billion | Rs8.51 Billion | Rs3.61 Billion | ▼ -27.9% |
| 2025 | 0.59x | Rs5.01 Billion | Rs8.52 Billion | Rs4.07 Billion | ▲ +54.8% |
| 2024 | 0.38x | Rs4.17 Billion | Rs10.97 Billion | Rs3.07 Billion | ▼ -40.2% |
| 2023 | 0.63x | Rs4.74 Billion | Rs7.47 Billion | Rs4.03 Billion | ▼ -3.0% |
| 2022 | 0.65x | Rs5.03 Billion | Rs7.68 Billion | Rs3.97 Billion | — |